Palvella Therapeutics, Inc (PVLA) stock news · rev $42.8M
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
This PVLA news page leads with what Palvella Therapeutics, Inc filed — not a scraped headline mill.
No cached 8-K sentence for PVLA yet. We will not pad this page with generic market recap.
Latest reported PVLA revenue for 2023-12-31 was $42.8M. Net income was -$24.5M. Revenue was up 65.3% from 2022-12-31 to 2023-12-31. PVLA currently screens at market cap $1.64B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PVLA stock page; for the tape open the quote page.
PVLA stock news FAQ
What are PVLA's latest revenue and net income?
Latest cached Palvella Therapeutics, Inc (PVLA) revenue for Dec 31, 2023 was $42.8M. Net income was -$24.5M. Statements: https://lician.com/financials/pvla
How did PVLA revenue change from the prior cached period?
Cached Palvella Therapeutics, Inc (PVLA) revenue was up 65.3% from $25.9M (Dec 31, 2022) to $42.8M (Dec 31, 2023). Statements: https://lician.com/financials/pvla
What is PVLA's market cap?
Palvella Therapeutics, Inc (PVLA) market cap is $1.64B on the latest cached fundamentals snapshot.
What kind of company is PVLA?
Palvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
Where is PVLA stock news listed?
Cached stock news for Palvella Therapeutics, Inc (PVLA) is listed at https://lician.com/news/pvla. Filings: https://lician.com/sec/pvla
Not investment advice.